CA
NZ
UK
AU
IND
US
Corcept Therapeutics (NASDAQ: CORT) delivered diluted earnings per share that surpassed analyst consensus for the quarter. Revenue increased 32% to $256.1 million, reflecting strong sales across its product portfolio. The company also raised its 2026 revenue outlook to a range of $1.1‑$1.2 billion, highlighting …
Filana Therapeutics, Inc. (NASDAQ: FLNA) has reported a decrease in its cash position to $82.7 million as of June 30, 2026, a notable drop from $95.5 million at the end of 2025. The decrease raises concerns for investors regarding the company’s liquidity, especially in …
GE HealthCare Technologies Inc. (NASDAQ: GEHC) has re‑organized its business into three reportable segments, spotlighting a newly created Advanced Imaging Solutions (AIS) division that posted $3,640 million in revenue for the quarter ended March 31 2026. The restructuring merges the former Imaging and Advanced …
Healthcare Triangle, Inc. This move marks a vital enhancement in the company's positioning to meet the Minimum Market Value of Listed Securities (MVLS) threshold, set at $5 million. Given that the market capitalization is currently around $3 million, these adjustments are critical for HCTI's …
Eton Pharmaceuticals, Inc. Food and Drug Administration (FDA). This new application seeks to allow KHINDIVI to treat pediatric patients under five years old, addressing a gap in the market for an FDA-approved hydrocortisone solution for younger children with adrenal insufficiency.
GE HealthCare (GEHC) has posted record orders in Q2 2026, revealing a persistent demand for its healthcare solutions despite facing margin pressures. The surge in orders indicates strong growth potential within the healthcare sector, supporting an 11.7% increase in share price to $71.63. However, …
HCW Biologics Inc. (NASDAQ: HCWB) completed a private placement that raised approximately $1.6 million by issuing a total of 618,682 units. Each unit contains either a share of the company’s common stock, which carries a par value of $0.0001 per share, or a pre‑funded …
Humana Inc. (NYSE: HUM) reported strong financial results for the second quarter of 2026, recording an adjusted earnings per share (EPS) of $7.61, significantly above the consensus estimate of $7.29. This figure represents a continued upward trend in the company's performance, and demonstrates effective …
Accuray Inc (NASDAQ: ARAY) has finalized a financing arrangement that provides a combined $55,000,000 of capital through the issuance of Series A Preferred Stock.
Align Technology Inc. (NASDAQ: ALGN) has reported impressive financial results for the second quarter of 2026, achieving record revenues of $1.06 billion. This figure signifies a year-over-year increase of 4.3% and highlights the company's resilience in a competitive market environment. The diluted earnings per …
Please wait processing your request...